The Pros and Cons of Insurtech Startup Expansion

Alternative Data Paired With Social Determinants Help Redraw Patient Health Outcomes

Novel Treatments Challenge Traditional Reimbursement

Clinical Pathways: How to Deliver Better Care and Outcomes

Why the Fee-For-Service Chassis Continues to Dominate Value-Based Purchasing and What to Do About It

Nevada's Public Option Continues Healthcare's Cost Versus Coverage Debate

Pages